HHS awards $171.5M for HIV/Infectious Disease Clinical Research Support Services to PPD Development LP
Contract Overview
Contract Amount: $17,155,112 ($17.2M)
Contractor: PPD Development LP
Awarding Agency: Department of Health and Human Services
Start Date: 2024-08-15
End Date: 2026-08-14
Contract Duration: 729 days
Daily Burn Rate: $23.5K/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
Place of Performance
Location: WILMINGTON, NEW HANOVER County, NORTH CAROLINA, 28401
Plain-Language Summary
Department of Health and Human Services obligated $17.2 million to PPD DEVELOPMENT LP for work described as: COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) Key points: 1. The contract focuses on critical research support for HIV and other infectious diseases. 2. PPD Development LP is the sole awardee for this specific delivery order. 3. The contract duration is 729 days, ending August 14, 2026. 4. The award falls under the Research and Development in Biotechnology (except Nanobiotechnology) NAICS code.
Value Assessment
Rating: good
The contract type is Cost Plus Fixed Fee, which allows for flexibility in research but requires careful monitoring of costs. Benchmarking against similar research support service contracts is needed to fully assess value.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a competitive bidding process. However, this specific award is a delivery order, and the overall contract vehicle's competition history is not detailed here.
Taxpayer Impact: The use of full and open competition is generally beneficial for taxpayers as it aims to secure the best value through market forces.
Public Impact
Supports critical research into HIV and other infectious diseases, potentially leading to new treatments or prevention methods. The funding will enable continued clinical research operations for NIAID programs. The contract's success could impact public health outcomes related to infectious diseases.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Lack of specific performance metrics in the provided data.
- Potential for cost overruns inherent in Cost Plus Fixed Fee contracts.
Positive Signals
- Awarded under full and open competition.
- Supports vital public health research.
Sector Analysis
This contract falls within the R&D in Biotechnology sector, which is crucial for medical advancements. Spending in this area is often driven by public health needs and scientific innovation.
Small Business Impact
The provided data does not indicate any specific set-asides for small businesses for this particular award. Further analysis of the parent contract or broader NIAID contracting would be needed.
Oversight & Accountability
Oversight will be managed by the National Institutes of Health (NIH). The effectiveness of oversight will depend on robust performance monitoring and adherence to the Cost Plus Fixed Fee contract terms.
Related Government Programs
- Research and Development in Biotechnology (except Nanobiotechnology)
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Cost Plus Fixed Fee contract type can lead to cost overruns if not managed tightly.
- Limited information on specific performance metrics.
- Potential for scope creep in research support services.
- Dependence on a single awardee for this delivery order.
Tags
research-and-development-in-biotechnolog, department-of-health-and-human-services, nc, delivery-order, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $17.2 million to PPD DEVELOPMENT LP. COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
Who is the contractor on this award?
The obligated recipient is PPD DEVELOPMENT LP.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $17.2 million.
What is the period of performance?
Start: 2024-08-15. End: 2026-08-14.
What is the specific breakdown of costs within the Cost Plus Fixed Fee structure, and how does it compare to industry standards for similar research support services?
The provided data does not detail the cost breakdown for this Cost Plus Fixed Fee contract. A thorough analysis would require access to the contract's financial clauses and comparison with benchmarks for similar services. This would help determine if the fixed fee component is reasonable and if the cost-reimbursement elements are being managed efficiently to prevent unnecessary expenditure.
What are the key performance indicators (KPIs) for this contract, and how will NIAID measure the success of PPD Development LP's support for research programs?
The provided data does not specify the Key Performance Indicators (KPIs) for this contract. Effective oversight requires clearly defined metrics related to research support timeliness, quality, and impact. NIAID's ability to track and evaluate PPD Development LP's performance against these KPIs will be crucial for ensuring the contract delivers value and contributes effectively to the research objectives.
How does the pricing of this delivery order compare to other contracts awarded for similar clinical research support services under full and open competition?
Without specific pricing details or comparable contract data, a direct price comparison is not possible. However, the fact that it was awarded under full and open competition suggests that the pricing was deemed competitive at the time of award. Further analysis would involve benchmarking the total value and duration against similar service contracts to assess cost-effectiveness.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology (except Nanobiotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Address: 929 N FRONT ST, WILMINGTON, NC, 28401
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $75,173,993
Exercised Options: $17,155,112
Current Obligation: $17,155,112
Actual Outlays: $8,503,137
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Parent Contract
Parent Award PIID: 75N93021D00035
IDV Type: IDC
Timeline
Start Date: 2024-08-15
Current End Date: 2026-08-14
Potential End Date: 2031-08-14 00:00:00
Last Modified: 2026-03-26
More Contracts from PPD Development LP
- Niaid HIV and Other Infectious Diseases Clinical Research Support Services (crss) — $329.8M (Department of Health and Human Services)
- Aids Research (basic) — $143.4M (Department of Health and Human Services)
- Niaid Clinical Site Monitoring — $135.1M (Department of Health and Human Services)
- Advanced Research and Development Activities for Novel Immunogenicity Assays and Sample Collection Technologies AS Part of Barda?s Continuing Support for Covid-19 Vaccine Development, Assessing Impact of Variants on Vaccine Immunogenicity, and Analyz — $126.5M (Department of Health and Human Services)
- Barda Will Implement a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial in the US to Evaluate the Safety and Efficacy of Novel Host-Directed Therapeutic Candidates in Hospitalized Adults With Ards — $117.4M (Department of Health and Human Services)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →